Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Healthlead Public Company Limited (HL) - Total Liabilities
Latest total liabilities as of September 2025: ฿527.40 Million THB
Based on the latest financial reports, Healthlead Public Company Limited (HL) has total liabilities worth ฿527.40 Million THB as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Healthlead Public Company Limited - Total Liabilities Trend (2017–2024)
This chart illustrates how Healthlead Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Healthlead Public Company Limited Competitors by Total Liabilities
The table below lists competitors of Healthlead Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alpha Microelectronics
TWO:8024
|
Taiwan | NT$35.14 Million |
|
Techbond Group Bhd
KLSE:5289
|
Malaysia | RM35.55 Million |
|
Cleanspace Holdings Ltd
AU:CSX
|
Australia | AU$8.41 Million |
|
Emperor Entertainment Hotel Limited
F:EM7A
|
Germany | €337.70 Million |
|
Cogra 48 Société Anonyme
PA:ALCOG
|
France | €10.56 Million |
|
IDP Corp Ltd.
KQ:332370
|
Korea | ₩4.70 Billion |
|
Shui-Mu International Co Ltd
TW:8443
|
Taiwan | NT$984.50 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Healthlead Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Healthlead Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Healthlead Public Company Limited (2017–2024)
The table below shows the annual total liabilities of Healthlead Public Company Limited from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ฿493.23 Million | +18.11% |
| 2023-12-31 | ฿417.62 Million | +20.63% |
| 2022-12-31 | ฿346.20 Million | +37.16% |
| 2021-12-31 | ฿252.41 Million | -7.62% |
| 2020-12-31 | ฿273.23 Million | +44.94% |
| 2019-12-31 | ฿188.50 Million | +20.43% |
| 2018-12-31 | ฿156.53 Million | -18.21% |
| 2017-12-31 | ฿191.37 Million | -- |